Jane Street’s Co-Diagnostics CODX Stock Holding History

Jane Street’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,613	Closed	-$432K	–	10365
2021 Q4	$432K	Sell	1,613 -1,734	-52%	-$455K	﹤0.01%	7523
2021 Q3	$977K	Buy	3,347 +450	+16%	+$131K	﹤0.01%	5953
2021 Q2	$717K	Sell	2,897 -363	-11%	-$93.3K	﹤0.01%	6536
2021 Q1	$933K	Sell	3,260 -863	-21%	-$344K	﹤0.01%	5587
2020 Q4	$1.15M	Sell	4,123 -1,077	-21%	-$399K	﹤0.01%	4414
2020 Q3	$2.12M	Buy	5,200 +1,480	+40%	+$760K	﹤0.01%	2942
2020 Q2	$2.16M	Buy	+3,720	New	+$1.7M	﹤0.01%	2956

Other funds holding CODX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAG

Private Advisory Group Redmond, Washington $1.85B AUM 50.66% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street's CODX Position: Q2 2026 in Review

Jane Street opened a new position in Co-Diagnostics (CODX) in Q2 2026: 89,240 shares worth $277K. The stake represents ﹤0.01% of the portfolio and ranks #9401 among its holdings. This is a return to the name: Jane Street previously reported a position in CODX as recently as Q4 2025.

Jane Street first reported a position in CODX in Q1 2020 and has held it in 18 quarters since. The position peaked at $793K in Q3 2020. 24 funds tracked by Wall St. Rank hold CODX as of Q2 2026.

Jane Street held 89,240 shares of Co-Diagnostics worth $277K as of Q2 2026.
Co-Diagnostics was a new Jane Street position in Q2 2026.
Co-Diagnostics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #9401 holding.
Jane Street first reported a position in Co-Diagnostics in Q1 2020 and has held it in 18 quarters since.
Jane Street's Co-Diagnostics position peaked at $793K in Q3 2020.
24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.